Metraipolis › archive › dc_d537ee84f129

Broadly neutralizing antibodies for HIV therapy in clinical trials: a systematic review — Europe PMC PMID:42387620

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42387620
DOI
10.1186/s40249-[numero omesso]-4
License (as archived)
solo-consultazione
Archived
2026-10-18T11:59:42.364Z
SHA-256 of the archived text
241edf7ccae1fa10bb7aa50fd2464159fa743e56023bd018ca788687fa675f37
Stable URL of this page
https://metraipolis.com/documento/dc_d537ee84f129

How to cite

Broadly neutralizing antibodies for HIV therapy in clinical trials: a systematic review — Europe PMC PMID:42387620 — Europe PMC (en), https://europepmc.org/article/MED/42387620 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d537ee84f129 (Metraipolis archive dc_d537ee84f129, sha256 241edf7ccae1fa10bb7aa50fd2464159fa743e56023bd018ca788687fa675f37)
BibTeX
@misc{dcd537ee84f129,
  title = {Broadly neutralizing antibodies for HIV therapy in clinical trials: a systematic review — Europe PMC PMID:42387620},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42387620},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d537ee84f129; sha256 241edf7ccae1fa10bb7aa50fd2464159fa743e56023bd018ca788687fa675f37},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42387620. Agents can read the archived copy with the MCP tool read_document.